ID
16483
Description
A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00191672
Link
https://clinicaltrials.gov/show/NCT00191672
Keywords
Versions (1)
- 7/18/16 7/18/16 -
Uploaded on
July 18, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Neoplasms NCT00191672
Eligibility Breast Neoplasms NCT00191672
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Measurable Disease
Data type
boolean
Alias
- UMLS CUI [1]
- C1513041
Description
Metastatic malignant neoplasm to brain
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Description
taxane | Metastatic Neoplasm
Data type
boolean
Alias
- UMLS CUI [1]
- C0215136
- UMLS CUI [2]
- C2939420
Description
Pregnancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
Description
gemcitabine
Data type
boolean
Alias
- UMLS CUI [1]
- C0045093
Similar models
Eligibility Breast Neoplasms NCT00191672
- StudyEvent: Eligibility
C0278488 (UMLS CUI [2])
C0031831 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2,1])
C0807679 (UMLS CUI [2,2])
C0679246 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C2939420 (UMLS CUI [2,2])
C0215136 (UMLS CUI [2])
C1514461 (UMLS CUI [2])
C2939420 (UMLS CUI [2])
No comments